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I N T R O D U C T I O N
Food allergy is an adverse health effect arising from a specific immune response that occurs reproducibly following exposure to a given food [1] . The main cause of food allergies in children under three years old is Cow's Milk Protein (CMP) [2] .
The estimated prevalence of Cow's Milk Protein Allergy (CMPA) is 2% to 3% in the first year of life [2] . In Brazil an observational study conducted in pediatricians' offices revealed a gastroenterologist-diagnosed prevalence of 5% in the group of patients [3] .
The immune mechanisms involved in CMPA may be immunoglobulin (Ig)E mediated (with production of IgE-specific antibodies), which presents immediate symptoms such as urticaria and angioedema, or the non IgEmediated (T-cell mediated), which manifests through later reactions, such as vomiting, diarrhea, colic and intestinal constipation. Mixed reactions (immediate and late) can also occur, such as eosinophilic esophagitis, eosinophilic gastroenteropathy, atopic dermatitis and asthma [1, [4] [5] [6] .
The diagnosis and treatment of CMPA is based on the exclusion of CMP from the diet. Cow's milk elimination without adequate replacement may impair the normal growth and development of the child [1, [4] [5] [6] [7] .
During the period of exclusion of CMP, a nutritional status assessment should be performed by the health professional to establish the adequacy of food consumption for the child's nutritional needs [1, 4, 5, 8] and family members must be oriented to perform a thorough reading of the labels of industrialized foods offered to their children [1, 5, 7, 9] . Despite the existence of several guidelines [1, [4] [5] [6] [7] [10] [11] [12] [13] for the diagnosis and treatment of CMPA, some surveys [6, 7, [14] [15] [16] [17] [18] [19] [20] [21] [22] have shown that the practices and knowledge of health professionals are not fully in line with these recommendations. Few studies have investigated the knowledge and practices of pediatricians and nutritionists about CMPA treatment. Studies [15, 16, 19] conducted in Brazil have shown gaps in knowledge and have confirmed that not all behaviors are consistent with the recommendations.
Thus, this study aimed to evaluate the knowledge and practice of pediatricians and dietitians about CMPA in infants, with an emphasis on issues related to the exclusion diet and nutritional status.
M E T H O D S

Study design
This study had a cross-sectional descriptive design involving a convenience sample of 406 professionals. Data collection was conducted from November 2014 to March 2016.
The invitation to professionals to participate in the study was issued randomly at five scientific events held in the city of 
Structured form
Data collection was performed through a structured and self-administered form that was previously described by Cortez et al. [15] . This form was reevaluated and adapted based on updates for the treatment of CMPA. The form was composed of an initial section to characterize the professional (i.e., gender, time since college graduation, graduate course and location of professional action). The second section consisted of questions about knowledge of and practices for the treatment of infants with CMPA.
The following statements were presented to enable the interviewees to express agreement, disagreement or lack of knowledge and multiple choice questions. 1) Casein is the only milk protein involved in triggering CMPA; 2) The early introduction of cow's milk increases the risk of CMPA development; 3) Exclusively breastfed infants can develop CMPA; 4) A child with CMPA may present a cross reaction to soybean proteins; 5) Goat's milk or milk from any other mammal (e.g., sheep, mare, or donkey) can be used as a substitute for cow's milk for children with CMPA; 6) Patients with lactose intolerance should exclude all foods containing CMP from the diet.
Knowledge about breastfeeding and bottle feeding
One question evaluated whether the interviewees knew the products that could be used to replace CMP in the diets of infants over six months of age with suspected nonIgE-mediated or IgE-mediated CMPA. The alternatives were presented with the definition of the type of formula (with the respective brand name) as follows: (1) extensively hydrolyzed formula; (2) soy protein-based formula; (3) Goat's milk; (4) soy extract-based beverage/ juice; (5) lactose-free milk formula; (6) amino acid-based formula; and (7) partially hydrolyzed formula. More than one option could be chosen for these questions. Some care practice scenarios were also presented.
We asked what the initial prescription for special formula would be for an infant less than six months of age (using infant formula) with suspected gastroesophageal reflux disease secondary to CMPA associated with a weight deficit. The following alternatives (with their brand names) were presented: (1) extensively hydrolyzed formula; (2) soy protein-based formula; (3) Goat's milk; (4) soy extract-based beverage/juice; (5) lactose-free milk formula; (6) amino acid-based formula; and (7) partially hydrolyzed formula.
Other food allergens
For children with CMPA, other allergenic foods, such as soy, eggs, fish and peanuts, should also be eliminated from the diet as a preventive measure to avoid other reactions.
Daily calcium requirements (clinical scenario)
A question was based on a clinical scenario involving a 15-month-old patient fed 450mL of extensively hydrolyzed formula with complementary feeding and whether this patient would require calcium supplementation. Three alternatives were offered as a response (yes, no and I do not know). Another issue addressed the recommendation for the daily calcium intake according to age group. The following question was asked: what total dose of calcium do you recommend as a daily intake (mg/day) for the following age groups? The response options were as follows: 0-6 months: 200, 260 or 400; 7-12 months: 260, 400 or 600; 13-36 months: 400, 700 or 900; another dose; and I do not know. Another question explored the need for calcium supplementation (considering the consumption of different substitution formulas) for patients with a CMPA. The following alternatives were presented: (1) for patients aged 0-6 months; (2) for patients aged 7-12 months; (3) for patients aged 13-36 months; and (4) other.
Reading of labels and identification of terms related to cow's milk and dairy products in industrialized products
The answers were based on yes and no alternatives. If the answer was yes, the interviewee chose which of the following ingredients should be recognized by the parents/guardians and excluded from the diet: maltodextrin; calcium; lactalbumin; casein; caseinate; hydrogenated vegetable fat; milk compound; calcium stearoyl lactyl lactate; lactic acid; serum proteins; lactic yeast; cocoa butter; and hydrolyzed or partially hydrolyzed milk protein.
Statistical Methods
Statistical calculations were performed using the Epi-Info software version 3.4.3 (Atlanta, Georgia, United States) by setting the level for rejection of the null hypothesis at 5%. The Chi-square test was used for the comparison of proportions. When necessary, the exact Fisher test was used.
R E S U L T S
A total of 406 professionals were interviewed (204 pediatricians and 202 nutritionists).
Regarding gender, women predominated, corresponding to 88.7% (360/406) of the sample. The percentage of female respondents was higher (p<0.001) among the nutritionists (97.0%; 196/202) than in the pediatric group (80.4%; 164/204).
All of the pediatricians worked in a clinic, outpatient clinic, basic health unit, inpatient/ intensive care unit, pediatric emergency and/ or family health program. Of the nutritionists, 23/202 (11.4%) did not work in nutritional assistance services for patients. Table 1 presents the results related to the knowledge and practices of the interviewees about CMPA and its treatment. Generally, the frequency of correct answers was greater among the pediatricians. The nutritionists had less knowledge about the ineffectiveness of milk from other mammals as a substitute for cow's milk and the exclusion of other allergenic foods to prevent other reactions. Notably, the highest frequency of incorrect responses for both the pediatricians and dietitians was found for the possibility of a cross-reaction between CMP and soy proteins. Figure 1 shows the products considered suitable by pediatricians and dietitians to replace CMP for infants with non-IgE-mediated CMPA (0-24 months) or IgE-mediated CMPA (older than six months). The infant formulas most frequently advocated were extensively hydrolyzed and amino acids. One result that should be highlighted is the use of soy protein-based formulas, which was considered by pediatricians in 34.5% of the non-IgE mediated reactions and 52.5% of the immediate reactions after six months of age and by nutritionists in 46.0% and 47.5% of the reactions, respectively. Between 1.5% and 21.0% of the interviewees would use non-acceptable alternatives for the treatment of CMPA, including goat's milk, a beverage or juice based on soy extract, lactosefree milk formula and partially hydrolyzed formula. Some significant differences were found according to the professional category. Regarding the orientation on reading industrialized product labels, 96.1% (196/204) of the pediatricians and 82.7% (167/202) of the dietitians (p<0.001) reported that they provided guidance to parents and/or guardians of children for the identification of all ingredients that might indicate the presence of CMP in industrialized products. greater among the pediatricians in relation to the ingredients that should or should not be excluded from the diets of patients with CMPA than among the nutritionists. The need for calcium supplementation was questioned in a clinical scenario involving a 15-month-old patient receiving 450mL of extensively hydrolyzed formula in addition to complementary feeding. Of the 202 pediatricians, 42.5% answered that they would supplement calcium. Accordingly, 62 (31.2%) of the 199 nutritionists would also provide this supplementation. We questioned in which age group calcium supplementation is generally necessary and found that 42.9% (85/198) of the pediatricians and 49.5% (100/202) of the nutritionists required supplementation between 13 and 36 months of age (p=0.223).
D I S C U S S I O N
Our results showed that the interviewees' knowledge was adequate for most of the contents investigated. However, a non-negligible portion of the professionals interviewed would prescribe inadequate cow's milk substitutes for an infant with suspected or diagnosed CMPA.
The results also showed that knowledge and practical guidelines should be improved about the reading of labels of industrialized products and the prescription of calcium supplements. This study meets the demands of pediatricians and nutritionists regarding the clinical practice of treating allergy to cow's milk proteins in infants. Based on this premise, it is important to highlight that these professionals present gaps in the knowledge of the treatment of this clinical entity, which may negatively impact the growth and development of these infants. Thus, our study makes an important diagnosis of the actual situation of the knowledge of these pediatricians and nutritionists about the theme.
Regarding Table 1 , most a greater number of nutritionists compared to pediatricians did not believe that a child under an exclusive breastfeeding period could develop CMPA. The same result was found regarding the possibility that milk from other animals could be used as a substitute for cow's milk. Previous study [15] also reported that most dietitians did not agree that infants could develop CMPA when exclusively breastfed. However, food ingested by the mother can be transferred to her child through breast milk [1, 4, 11] . For example, 49.0% of published cases of eosinophilic colitis occurred during exclusive breastfeeding [23] .
In total, 44.6% of nutritionists and 11.8% of pediatricians agreed that milk from other animals could be used as a substitute for cow's milk for children with CMPA. Previous Research [15] showed that 15.2% of pediatricians and 13.7% of nutritionists agreed that milk from other mammals could be used as a suitable substitute for cow's milk. The inadequacy of the use of the milk from other animals is due to the similarity of the proteins from these mammals with the proteins in cow's milk (i.e., there is a high possibility of the occurrence of a crossallergic reaction) [4, 24] . Conversely, the reaction is not crossed with soy formula. Instead, children with CMPA who develop gastrointestinal tract involvement when soy formula is initiated as a substitute exhibit sensitization [1, [5] [6] [7] 25] .
Although soy formulas are not recommended for infants with non-IgEmediated CMPA, the use of this therapeutic option is accepted in infants over six months of age with an IgE-mediated allergy because sensitization to soy formula occurs less often in the immediate reaction [1, [4] [5] [6] [7] 10, 12, 25] . Our results showed that almost all pediatricians and nutritionists wrongly considered a cross-reaction between cow's milk and soybeans a possibility, when in fact there is the possibility of developing sensitization and a reaction after exposure to this type of protein.
Approximately 35.0 to 46.0% of the interviewees (Figure 1 ) considered soy protein as an option for children with non-IgE mediated reactions. Conversely, approximately half of the interviewees did not consider soy formula as an option for cow's milk substitution for children with IgE-mediated reactions over six months of age, although this approach is suggested by several guidelines [1, 5, 7, [10] [11] [12] 25] . Virtually all of the guidelines recommend that extensively hydrolyzed formulas be used as the first alternative for children with suspected or diagnosed CMPA, whereas amino acid formulas are recommended for use in severe cases and for patients with persistent symptoms using an extensively hydrolyzed formula [4, 5, 7, 11, 12] .
In our study, approximately 80% of pediatricians recognized the extensively hydrolyzed formulas as an option for CMPA treatment, and approximately 70.0 and 76% of these professionals knew that they could indicate amino acid formulas for cases with non-IgE-mediated and IgE-mediated reactions, respectively. Approximately half of the nutritionists respondents recognized extensively hydrolyzed and amino acid formulas as substitutes for cow's milk. This question sought to explore all possible options for the replacement of cow's milk in infants with CMPA. Cortez et al. [15] found that 66% of pediatricians and 48% of nutritionists would indicate at least one product considered inappropriate for the treatment of CMPA.
The choice of substitute formula was evaluated in the question about the first option that would be recommended for a child less than 6 months of age with a weight deficit using infant formula with suspected gastroesophageal reflux secondary to CMPA. For this case, 58.2% of pediatricians would prescribe an extensively hydrolyzed formula obeying the guidelines [2, 4, 5, 7, 11, 12] . However, 24.0% of the respondents would prescribe an amino acid formula. In this context, we should note that the guidelines contain no clear definition of serious cases. Thus, the decision to prescribe an amino acid formula was probably motivated by considering the presented case as a serious form of CMPA by least some of these interviewees, since the case presented a weight deficit. Another explanation is that some suggestions from the literature consider the possibility of using amino acid formulas to diagnose CMPA more quickly [26] .
During the adoption of the exclusion of CMP diet for children with CMPA, relatives and/or guardians should be guided on reading the labels of industrialized products. Our results were similar to those found in a previous studies [9, 15, 27] which showed that the majority of respondents had difficulty recognizing the terms/ingredients that indicated the presence of cow's milk allergens. In this context, since July 2015, food and beverage labels have been required by the promulgation of the Resolution of the Collegiate Board of Directors -RDC No.26 of the Agência Nacional de Vigilância Sanitária (ANVISA, National Sanitary Surveillance Agency) [28] , to contain a description of 18 allergy-causing food ingredients/products, including milk. This regulation is expected to provide conditions for a better understanding of labels by patients and caregivers, thereby solving problems in the identification of allergens demonstrated in Brazil [9, 27] and other countries [29, 30] .
Regarding the recommendation for the daily calcium intake for the different age groups, our findings showed a low level of satisfaction among the professionals interviewed. A previous study [15] showed that only 22% of pediatricians and 61% of nutritionists knew the calcium recommendations for all age groups. Some of this knowledge gap is possibly due to the recent changes in the Dietary Reference Intakes (DRI) [31] following the release of new values in 2011 [i.e., 200mg/day (0-6 months), 260 mg/day (7-12 months) and 700mg/day (13-36 months)]. There is no need for calcium supplementation in infants less than one year of age who are receiving more than 500mL/day of infant formulas for specific dietary needs, since the formulas meet the nutritional needs of the patients [32] . For patients older than one year, the nutritional composition of the diet and the volume of food ingested should be considered, because calcium supplementation may be necessary [2, 32] . Another important nutrient is vitamin D, which aids in the intestinal absorption of calcium and bone metabolism [32] .
For the clinical scenario involving the 15-month-old patient receiving 450mL of an extensively hydrolyzed formula in addition to a complementary diet, the percentage of professionals who would not indicate calcium supplementation was higher among the pediatricians than among the nutritionists. The extensively hydrolyzed formulas available in the Brazilian market contain approximately 50mg of calcium per 100mL of product. A 15-month-old patient who ingests 450mL of the formula daily will receive approximately 225mg of calcium. Considering that the other foods present in the patient's diet contain 100mg of calcium, 375mg of calcium should be supplemented.
One of the limitations of our work was that the data collection was performed only at scientific events in the city of São Paulo. In addition to the regional character, professionals who participate in scientific events can be assumed to be more concerned with their scientific knowledge and therefore do not accurately represent the universe of professionals. However, our results are generally similar to the results from other studies [17] [18] [19] [20] [21] [22] [23] [24] [25] that evaluated the knowledge and practices of health professionals. These studies [17] [18] [19] [20] [21] [22] [23] [24] [25] used procedures for recruiting interviewees that were similar or different to the procedure used herein.
C O N C L U S I O N
We conclude that gaps still exist in the knowledge and practices of pediatricians and nutritionists about CMPA treatment. Therefore, educational strategies should be proposed and performed to enable these professionals to act in an adequate manner in the establishment of the diagnosis and treatment of CMPA in infants. Thus, it is possible for these professionals to review their therapeutic behaviors for guarantee of the quality of life of the infant, that is, the faster reversal of clinical manifestations and nutritional recovery, avoiding the use of dietary elimination based on inadequate behaviors and that can lead to nutritional deficits, besides rationalizing the use of resources in the treatment of patients with CMPA.
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